fda warning letters glp-1 compounding september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading Why the FDA Issued 30

The rate at which the medical community is giving out these drugs tells me that were hitting a lot of people with a predisposition for eating disorders. Turner hopes that clinicians prescribing these drugs will take screening for eating disorders seriously and recognize that people can have eating disorders at every size

Additionally, patients need to purchase injection supplies such as needles and sharps containers, though these are relatively inexpensive (usually under 10 monthly)

Focus on protein consumption

All of these support balanced appetite hormones and longer-term success

Full disclaimer included at the end of this article

Retrieved 7 April 2023